290 related articles for article (PubMed ID: 9209321)
1. Inhibition of HIV-1 replication by targeting the Rev protein.
Nakaya T; Iwai S; Fujinaga K; Otsuka E; Ikuta K
Leukemia; 1997 Apr; 11 Suppl 3():134-7. PubMed ID: 9209321
[TBL] [Abstract][Full Text] [Related]
2. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Lee SW; Gallardo HF; Gilboa E; Smith C
J Virol; 1994 Dec; 68(12):8254-64. PubMed ID: 7966618
[TBL] [Abstract][Full Text] [Related]
5. Decoy approach using RNA-DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 Rev protein.
Nakaya T; Iwai S; Fujinaga K; Sato Y; Otsuka E; Ikuta K
Antimicrob Agents Chemother; 1997 Feb; 41(2):319-25. PubMed ID: 9021186
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
Campbell LH; Borg KT; Arrigo SJ
Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
[TBL] [Abstract][Full Text] [Related]
7. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
[TBL] [Abstract][Full Text] [Related]
8. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production.
Duc Dodon M; Mikaélian I; Sergeant A; Gazzolo L
Virology; 2000 Apr; 270(1):43-53. PubMed ID: 10772978
[TBL] [Abstract][Full Text] [Related]
9. Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.
Duan L; Zhu M; Ozaki I; Zhang H; Wei DL; Pomerantz RJ
Gene Ther; 1997 Jun; 4(6):533-43. PubMed ID: 9231069
[TBL] [Abstract][Full Text] [Related]
10. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
Fang J; Kubota S; Yang B; Zhou N; Zhang H; Godbout R; Pomerantz RJ
Virology; 2004 Dec; 330(2):471-80. PubMed ID: 15567440
[TBL] [Abstract][Full Text] [Related]
11. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
[TBL] [Abstract][Full Text] [Related]
12. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
Nam YS; Petrovic A; Jeong KS; Venkatesan S
J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
[TBL] [Abstract][Full Text] [Related]
14. Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.
Shimane K; Kodama EN; Nakase I; Futaki S; Sakurai Y; Sakagami Y; Li X; Hattori T; Sarafianos SG; Matsuoka M
Int J Biochem Cell Biol; 2010 Sep; 42(9):1482-8. PubMed ID: 20580677
[TBL] [Abstract][Full Text] [Related]
15. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
Modem S; Reddy TR
J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA molecules.
Fineberg K; Fineberg T; Graessmann A; Luedtke NW; Tor Y; Lixin R; Jans DA; Loyter A
Biochemistry; 2003 Mar; 42(9):2625-33. PubMed ID: 12614157
[TBL] [Abstract][Full Text] [Related]
18. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
[TBL] [Abstract][Full Text] [Related]
19. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro.
Daly TJ; Cook KS; Gray GS; Maione TE; Rusche JR
Nature; 1989 Dec; 342(6251):816-9. PubMed ID: 2481237
[TBL] [Abstract][Full Text] [Related]
20. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
Fischer M; Joos B; Hirschel B; Bleiber G; Weber R; Günthard HF;
J Infect Dis; 2004 Dec; 190(11):1979-88. PubMed ID: 15529263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]